5 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Yiling Pharmaceutical Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Pharmacokinetics Study for KT07 Capsule Low dose KT07, High dose KT07, Low dose Placebo - Healthy Adult Subjects, Pharmacokinetics | Phase 1 | Completed | Yiling Pharmaceutical Inc. | 26 | 2022-01-07 | 2022-10-17 |
| A Clinical Study Trial of Phenlarmide in China Phenlarmide Tablets, Placebos - Parkinson Disease | Phase 1 | Completed | Yiling Pharmaceutical Inc. | 36 | 2019-12-17 | 2021-12-14 |
| A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China Finamine tablets, Placebo tablets - Parkinson Disease | Phase 1 | Completed | Yiling Pharmaceutical Inc. | 34 | 2017-08-15 | 2021-12-14 |
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China Felbinac Trometamol Injection, Placebo - Healthy | Phase 1 | Completed | Yiling Pharmaceutical Inc. | 58 | 2017-07-17 | 2019-11-18 |
| A Clinical Trial of KT07 Capsule in the U.S.A KT07 Capsule, Placebo - Influenza, Human | Phase 2 | Completed | Yiling Pharmaceutical Inc. | 391 | 2016-09-01 | 2020-08-31 |
Parkinson Disease (2) · Influenza, Human (1)
Saline Solution (1)
China (3) · United States (2)
Nan Zhang, PhD (1) · Xuedong Gao, MD (1) · Yanhua Ding, MD (1)